Description

The purpose of this Notice of Amendment is to notify that Health Canada will add Epinephrine topical solution for hemostasis when sold at a concentration equal to or greater than 1 mg/ml (1:1000) to the Prescription Drug List (PDL). Both the Human and the Veterinary parts of the PDL were revised.

Resources

Name	Format	Description	Link
Notice of Amendment: Prescription Drug List (PDL): Epinephrine (topical solution)	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/amendment-epinephrine.html
Notice of Amendment: Prescription Drug List (PDL): Epinephrine (topical solution)	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/liste-drogues-ordonnance/avis-concernant-modifications/modification-epinephrine.html

Tags

Topics

Categories